The effect of early versus delayed challenge after vaccination in controlling SHIV 89.6P infection

Virology

Volumn 381, Issue 1, 2008, Pages 75-80

  Chavez, Leslie L ^a   Davenport, Miles P ^b   Shiver, John W ^c   Tussey, Lynda G ^c   Cox, Kara S ^c   Bachinsky, Margaret ^c   Wang, Fubao ^c   Huang, Lingyi ^c   Schleif, William A ^c   Davies, Mary Ellen ^c   Tang, Aimin ^c   Casimiro, Danilo R ^c   Perelson, Alan S ^a   Ribeiro, Ruy M ^a  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

CD8; Challenge time; Delayed response; HIV; Modeling; Vaccine

Indexed keywords

ADENOVIRUS VECTOR; VIRUS VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; MONKEY; MONKEY DISEASE; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; SIMIAN VIRUS; SURVIVAL RATE; T CELL DEPLETION; TREATMENT OUTCOME; VACCINATION; VIRUS LOAD;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; MACACA MULATTA; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TIME FACTORS; VACCINATION; VIRAL LOAD;

ADENOVIRIDAE; ANIMALIA; MACACA; MACACA MULATTA; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 54049097432     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.07.042     Document Type: Article

References (23)

1. Abdel-Motal U.M., Gillis J., Manson K., Wyand M., Montefiori D., Stefano-Cole K., Montelaro R.C., Altman J.D., and Johnson R.P. Kinetics of expansion of SIV Gag-specific CD8+ T lymphocytes following challenge of vaccinated macaques. Virology 333 2 (2005) 226-238
2. Anderson D.E., Singapuri A., Kang K.H., Montefiori D.C., and Torres J.V. Timing of retroviral infection influences anamnestic immune response in vaccinated primates. Viral Immunol. 18 4 (2005) 689-694
3. Appay V., and Rowland-Jones S.L. The assessment of antigen-specific CD8+ T cells through the combination of MHC class I tetramer and intracellular staining. J. Immunol. Methods 268 1 (2002) 9-19
4. Borsetti A., Baroncelli S., Maggiorella M.T., Bellino S., Moretti S., Sernicola L., Belli R., Ridolfi B., Farcomeni S., Negri D.R., Cafaro A., Ensoli B., and Titti F. Viral outcome of simian-human immunodeficiency virus SHIV-89.6P adapted to cynomolgus monkeys. Arch. Virol. 153 3 (2008) 463-472
5. Casimiro D.R., Wang F., Schleif W.A., Liang X., Zhang Z.Q., Tobery T.W., Davies M.E., McDermott A.B., O'Connor D.H., Fridman A., Bagchi A., Tussey L.G., Bett A.J., Finnefrock A.C., Fu T.M., Tang A., Wilson K.A., Chen M., Perry H.C., Heidecker G.J., Freed D.C., Carella A., Punt K.S., Sykes K.J., Huang L., Ausensi V.I., Bachinsky M., Sadasivan-Nair U., Watkins D.I., Emini E.A., and Shiver J.W. Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag. J. Virol. 79 24 (2005) 15547-15555
6. Champagne P., Ogg G.S., King A.S., Knabenhans C., Ellefsen K., Nobile M., Appay V., Rizzardi G.P., Fleury S., Lipp M., Forster R., Rowland-Jones S., Sekaly R.P., McMichael A.J., and Pantaleo G. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410 6824 (2001) 106-111
7. Davenport M.P., Ribeiro R.M., and Perelson A.S. Kinetics of virus-specific CD8+ T cells and the control of human immunodeficiency virus infection. J. Virol. 78 18 (2004) 10096-10103
8. Davenport M.P., Zhang L., Bagchi A., Fridman A., Fu T.M., Schleif W., Shiver J.W., Ribeiro R.M., and Perelson A.S. High-potency human immunodeficiency virus vaccination leads to delayed and reduced CD8+ T cell expansion but improved virus control. J. Virol. 79 15 (2005) 10059-10062
9. Davenport M.P., Zhang L., Shiver J.W., Casmiro D.R., Ribeiro R.M., and Perelson A.S. Influence of peak viral load on the extent of CD4+ T cell depletion in simian HIV infection. J. Acquir. Immune Defic. Syndr. 41 3 (2006) 259-265
10. Davenport M.P., Ribeiro R.M., Zhang L., Wilson D.P., and Perelson A.S. Understanding the mechanisms and limitations of immune control of HIV. Immunol. Rev. 216 (2007) 164-175
11. De Boer R.J., Homann D., and Perelson A.S. Different dynamics of CD4+ and CD8+ T cell responses during and after acute lymphocytic choriomeningitis virus infection. J. Immunol. 171 8 (2003) 3928-3935
12. Feinberg M.B., and Moore J.P. AIDS vaccine models: challenging challenge viruses. Nat. Med. 8 3 (2002) 207-210
13. Johnston M.I., and Fauci A.S. An HIV vaccine-evolving concepts. N. Engl. J. Med. 356 20 (2007) 2073-2081
14. Koopman G., Mortier D., Hofman S., Mathy N., Koutsoukos M., Ertl P., Overend P., van Wely C., Thomsen L.L., Wahren B., Voss G., and Heeney J.L. Immune-response profiles induced by human immunodeficiency virus type 1 vaccine DNA, protein or mixed-modality immunization: increased protection from pathogenic simian-human immunodeficiency virus viraemia with protein/DNA combination. J. Gen. Virol. 89 Pt 2 (2008) 540-553
15. Oxenius A., Gunthard H.F., Hirschel B., Fidler S., Weber J.N., Easterbrook P.J., Bell J.I., Phillips R.E., and Price D.A. Direct ex vivo analysis reveals distinct phenotypic patterns of HIV-specific CD8(+) T lymphocyte activation in response to therapeutic manipulation of virus load. Eur. J. Immunol. 31 4 (2001) 1115-1121
16. Patterson L.J., Beal J., Demberg T., Florese R.H., Malkevich N., Venzon D., Aldrich K., Richardson E., Kalyanaraman V.S., Kalisz I., Lee E.M., Montefiori D.C., Robey F.A., and Robert-Guroff M. Replicating adenovirus HIV/SIV recombinant priming alone or in combination with a gp140 protein boost results in significant control of viremia following a SHIV(89.6P) challenge in Mamu-A01 negative rhesus macaques. Virology (2008)
17. Pinheiro J.C.B., and Douglas M. Mixed-Effects Models in S and S-Plus. Statistics and Computing (2000), Springer Verlag New York, LLC, New York
18. Reynolds M.R., Rakasz E., Skinner P.J., White C., Abel K., Ma Z.M., Compton L., Napoe G., Wilson N., Miller C.J., Haase A., and Watkins D.I. CD8+ T-lymphocyte response to major immunodominant epitopes after vaginal exposure to simian immunodeficiency virus: too late and too little. J. Virol. 79 14 (2005) 9228-9235
19. Ridolfi B., Genovese D., Argentini C., Maggiorella M.T., Sernicola L., Butto S., Titti F., Borsetti A., and Ensoli B. Tat protein vaccination of cynomolgus macaques influences SHIV-89.6P(cy243)epitope variability. Virus Genes 36 1 (2008) 105-115
20. Sadagopal S., Amara R.R., Kannanganat S., Sharma S., Chennareddi L., and Robinson H.L. Expansion and exhaustion of T cell responses during mutational escape from long-term viral control in two DNA/MVA vaccinated and SHIV-89.6P challenged macaques. J. Virol. (2008)
21. Shiver J.W., Fu T.M., Chen L., Casimiro D.R., Davies M.E., Evans R.K., Zhang Z.Q., Simon A.J., Trigona W.L., Dubey S.A., Huang L., Harris V.A., Long R.S., Liang X., Handt L., Schleif W.A., Zhu L., Freed D.C., Persaud N.V., Guan L., Punt K.S., Tang A., Chen M., Wilson K.A., Collins K.B., Heidecker G.J., Fernandez V.R., Perry H.C., Joyce J.G., Grimm K.M., Cook J.C., Keller P.M., Kresock D.S., Mach H., Troutman R.D., Isopi L.A., Williams D.M., Xu Z., Bohannon K.E., Volkin D.B., Montefiori D.C., Miura A., Krivulka G.R., Lifton M.A., Kuroda M.J., Schmitz J.E., Letvin N.L., Caulfield M.J., Bett A.J., Youil R., Kaslow D.C., and Emini E.A. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415 6869 (2002) 331-335
22. R Development Core Team, 2008. R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org.
23. UNAIDS and WHO. AIDS epidemic update December 2007 (2007), Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO)